AAAAAA

   
Results: 1-22 |
Results: 22
Two new coordination polymers differentiated by C-H center dot center dot center dot O hydrogen bonding - synthesis and crystal structure of [(oxa)M(DPA)]
Authors: Lu, JY Schroeder, TJ Babb, AM Olmstead, M
Citation: Jy. Lu et al., Two new coordination polymers differentiated by C-H center dot center dot center dot O hydrogen bonding - synthesis and crystal structure of [(oxa)M(DPA)], POLYHEDRON, 20(19), 2001, pp. 2445-2449
Economics of the antithymocyte globulins Thymoglobulin (R) and Atgam (R) in the treatment of acute renal transplant rejection
Authors: Schnitzler, MA Woodward, RS Lowell, JA Amir, L Schroeder, TJ Singer, GG Brennan, DC
Citation: Ma. Schnitzler et al., Economics of the antithymocyte globulins Thymoglobulin (R) and Atgam (R) in the treatment of acute renal transplant rejection, PHARMACOECO, 17(3), 2000, pp. 287-293
The clinical and economic potential of cyclosporin drug interactions
Authors: Martin, JE Daoud, AJ Schroeder, TJ First, MR
Citation: Je. Martin et al., The clinical and economic potential of cyclosporin drug interactions, PHARMACOECO, 15(4), 1999, pp. 317-337
Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay
Authors: Regan, JF Campbell, K Van Smith, L Schroeder, TJ Womble, D Kano, J Buelow, R
Citation: Jf. Regan et al., Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay, TRANSPL IMM, 7(2), 1999, pp. 115-121
Correlation of histology to clinical rejection reversal: A Thymoglobulin Multicenter Trial report
Authors: Gaber, LW Moore, LW Gaber, AO Tesi, RJ Meyer, J Schroeder, TJ
Citation: Lw. Gaber et al., Correlation of histology to clinical rejection reversal: A Thymoglobulin Multicenter Trial report, KIDNEY INT, 55(6), 1999, pp. 2415-2422
The US multicenter double-blind, randomized, phase III trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design
Authors: Schroeder, TJ Moore, LW Gaber, LW Gaber, AO First, MR
Citation: Tj. Schroeder et al., The US multicenter double-blind, randomized, phase III trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design, TRANSPLAN P, 31(3B), 1999, pp. 1S-6S
Costs savings associated with thymoglobulin for treatment of acute renal transplant rejection in patient subsets
Authors: Schnitzler, MA Woodward, RS Lowell, JA Singer, GG Amir, L Horn, HR Kano, JM Schroeder, TJ Brennan, DC
Citation: Ma. Schnitzler et al., Costs savings associated with thymoglobulin for treatment of acute renal transplant rejection in patient subsets, TRANSPLAN P, 31(3B), 1999, pp. 7S-8S
Validity of open labeled versus blinded trials: A meta-analysis comparing neoral and sandimmune
Authors: Shah, MB Martin, JE Schroeder, TJ First, MR
Citation: Mb. Shah et al., Validity of open labeled versus blinded trials: A meta-analysis comparing neoral and sandimmune, TRANSPLAN P, 31(1-2), 1999, pp. 217-219
One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation
Authors: Khosla, UM Martin, JE Baker, GM Schroeder, TJ First, MR
Citation: Um. Khosla et al., One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 274-275
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune
Authors: First, MR Weiskittel, P Burton, ML Shah, MB Dreyer, D Fleck, P Bey, C Peddi, VR Canafax, DM Schroeder, TJ
Citation: Mr. First et al., Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune, TRANSPLAN P, 31(1-2), 1999, pp. 324-325
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients
Authors: Gaston, R Alloway, RR Gaber, AO Rossi, SJ Schroeder, TJ Irish, WD Canafax, DM First, MR
Citation: R. Gaston et al., Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients, TRANSPLAN P, 31(1-2), 1999, pp. 326-327
Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients
Authors: Fisher, RA Pan, SH Rossi, SJ Schroeder, TJ Irish, WD Canafax, DM Lopez, RR
Citation: Ra. Fisher et al., Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients, TRANSPLAN P, 31(1-2), 1999, pp. 394-395
Graft outcome in patients with biopsy-proven chronic renal allograft rejection
Authors: Peddi, VR Schroeder, TJ Weiskittel, P First, MR
Citation: Vr. Peddi et al., Graft outcome in patients with biopsy-proven chronic renal allograft rejection, TRANSPLAN P, 31(1-2), 1999, pp. 1308-1309
A blinded retrospective analysis of renal allograft pathology using the banff schema - Implications for clinical management
Authors: Dean, DE Kamath, S Peddi, VR Schroeder, TJ First, MR Cavallo, T
Citation: De. Dean et al., A blinded retrospective analysis of renal allograft pathology using the banff schema - Implications for clinical management, TRANSPLANT, 68(5), 1999, pp. 642-645
The evaluation of the safety and tolerability of two formulations of cyclosporine: Neoral and sandimmune - A meta-analysis
Authors: Shah, MB Martin, JE Schroeder, TJ First, MR
Citation: Mb. Shah et al., The evaluation of the safety and tolerability of two formulations of cyclosporine: Neoral and sandimmune - A meta-analysis, TRANSPLANT, 67(11), 1999, pp. 1411-1417
Pharmacokinetics of tacrolimus and cyclosporine in short-bowel syndrome
Authors: Thielke, J Martin, J Weber, FL Schroeder, TJ Goretsky, S Hanto, DW
Citation: J. Thielke et al., Pharmacokinetics of tacrolimus and cyclosporine in short-bowel syndrome, LIVER TR S, 4(5), 1998, pp. 432-434
Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral
Authors: First, MR Alloway, R Schroeder, TJ
Citation: Mr. First et al., Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral, CLIN TRANSP, 12(6), 1998, pp. 518-524
Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method
Authors: First, MR Weiskittel, P Shah, M Peddi, VR Canafax, D Schroeder, TJ
Citation: Mr. First et al., Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method, TRANSPLAN P, 30(8), 1998, pp. 3955-3957
A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral
Authors: Shah, MB Martin, JE Schroeder, TJ First, MR
Citation: Mb. Shah et al., A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral, TRANSPLAN P, 30(8), 1998, pp. 4048-4053
Tacrolimus use in kidney-pancreas recipients is associated with less acuterenal dysfunction than cyclosporine
Authors: Fleck, PR Schroeder, TJ Dauod, AJ Peddi, VR First, MR
Citation: Pr. Fleck et al., Tacrolimus use in kidney-pancreas recipients is associated with less acuterenal dysfunction than cyclosporine, TRANSPLAN P, 30(8), 1998, pp. 4070-4072
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus
Authors: Daoud, AJ Schroeder, TJ Shah, M Hariharan, S Peddi, VR Weiskittel, P First, MR
Citation: Aj. Daoud et al., A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus, TRANSPLAN P, 30(8), 1998, pp. 4079-4081
Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation
Authors: Baker, GM Martin, JE Jang, R Schroeder, TJ Armitstead, JA Myre, S First, MR
Citation: Gm. Baker et al., Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation, TRANSPLAN P, 30(8), 1998, pp. 4082-4084
Risultati: 1-22 |